EF
Therapeutic Areas
DermTech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| DermTech Melanoma Test (2-GEP) | Early detection of melanoma in equivocal pigmented lesions | Commercial |
Leadership Team at DermTech
BJ
Burkhard Jansen
President
JT
Jeremy Teraoka
Head of Finance
JE
James E. Stowers III
Chairman of the Board
JA
John Appleby
Director
NB
Neal Bhatia
Clinical Advisor
LF
Laura Ferris
Clinical Advisor
MK
Mark Kaufmann
Clinical Advisor
DS
Daniel Siegel
Clinical Advisor
MS
Maral Skelsey
Clinical Advisor
FK
Frank Koranda
Outside Legal Counsel